The trademark application MY HEARTPATH was filed by Amgen Inc., a U.S. corporation (the "Applicant"). The application was published for oppositions on October 22, 2020, and it was registered by office on January 29, 2021 without any oppositions.
The application was filed in English (French was selected as the second language).
Change of name and professional address of the trademark registration was recorded on November 5, 2023.
Goods And Services
The mark was filed in class 9 with Downloadable application software for mobile devices to enable cardiovascular patients to record, manage and display healthcare information, health goals, and medical appointments.
The mark was filed in class 44 with Providing healthcare information to patients on the patients' past cardiovascular events, steps to take in recovery, preparation for medical appointments, and setting and achieving health goals.